Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.395 USD | -0.18% |
|
-4.65% | -18.84% |
06-11 | AREX Capital Management Solicits Proxies from Shareholders of Enhabit | CI |
06-11 | Enhabit May Seeks Acquisitions | CI |
Strengths
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- The company's share price in relation to its net book value makes it look relatively cheap.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- Low profitability weakens the company.
- The company is in debt and has limited leeway for investment
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 45.71 times its estimated earnings per share for the ongoing year.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last few months, analysts have been revising downwards their earnings forecast.
- Over the past four months, analysts' average price target has been revised downwards significantly.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-18.84% | 422M | - | ||
-3.48% | 3.01B | B- | ||
+29.00% | 1.95B | C | ||
0.00% | 1.83B | - | ||
+62.50% | 678M | D+ | ||
-30.97% | 149M | - | ||
-11.33% | 136M | - | ||
+9.62% | 66.59M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- EHAB Stock
- Ratings Enhabit, Inc.